NRX set its annual meeting for December 17 and revised deadlines for shareholder proposals. The filing covers meeting procedures, not a change to its business or finances, so it does not change the company's outlook.
This filing changes how shareholders submit proposals and director nominations, but reports no change to NRX's products, sales, or finances. It therefore leaves the company's outlook unchanged.
Follow NRX Pharmaceuticals, Inc. (NRXP) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for NRXP